Total Count 252

SPIMACO - Latest News

07/09/2025
SPIMACO to launch new products, expand in Africa, Europe: Vice Chairman
Argaam
28/08/2025
SPIMACO CEO contract ends; Ahmed Aljedai to stay in charge
Argaam
13/08/2025
SPIMACO updates 2025 guidance
Argaam Special
05/08/2025
SPIMACO CFO says private sector, expansions to drive Q3 growth
Argaam
27/07/2025
SPIMACO inaugurates oncology, high-potent drug plant
Argaam
14/07/2025
Morgan Stanley 'market maker' for 40 TASI, Nomu firms
Argaam
06/07/2025
United Securities issues Q2 2025 earnings forecast
Argaam
03/07/2025
Al Rajhi Capital issues earnings estimates for Q2 2025
Argaam
30/06/2025
SPIMACO shareholders OK dividend freeze for 2024
Argaam
28/05/2025
SPIMACO updates 2025 guidance
Argaam Special
15/05/2025
SPIMACO's market share hits 12.1%, positive performance to sustain: CFO
Argaam Special
14/04/2025
Al Rajhi Capital issues Q1 2025 profit forecasts for TASI-listed firms
Argaam
08/04/2025
SPIMACO appoints Khalid Al-Gwaiz as Chairman, Ahmed Aljedai as Vice Chairman
Argaam
27/03/2025
SPIMACO board proposes dividend freeze for 2024
Argaam
27/03/2025
SPIMACO signs deal with China’s CNBG to supply, manufacture vaccines
Argaam
26/03/2025
SPIMACO signs agreement with CanSinoBIO to supply vaccines
Argaam
27/02/2025
SPIMACO elects board members for upcoming term
Argaam
17/02/2025
What do analysts expect from SPIMACO’s Q4 2024 results?
Argaam Special
12/02/2025
SPIMACO CEO agrees to retain post for 6 additional months
Argaam
29/01/2025
SPIMACO shareholders to elect board members on Feb. 26
Argaam
19/01/2025
SPIMACO inks sale, distribution contract for SAR 164.1M annually
ِArgaam
09/01/2025
United Securities issues Q4 2024 earnings forecasts
Argaam
02/01/2025
Al Rajhi Capital issues Q4 2024 profit forecasts for TASI-listed firms
Argaam Special
25/12/2024
SPIMACO obtains SAR 220M credit facilities from Alinma Bank
Argaam
24/12/2024
Alawwal Capital initiates coverage on SPIMACO
Argaam
23/12/2024
SPIMACO reviews 2024 guidance
Argaam Special
04/12/2024
SPIMACO says deal to buy 68% of Osmopharm, exit SPIMACO Misr scrapped
ِArgaam
24/11/2024
United Securities says SPIMACO’s Q3 2024 topline below estimate, lowers TP
Argaam
24/11/2024
SPIMACO approves CEO request not to renew contract
Argaam
14/11/2024
SPIMACO extends deadline to buy 68% of Osmopharm, exit SPIMACO Misr
Argaam
31/10/2024
Analyst forecasts for SPIMACO's Q3 2024 financials
Argaam Special
07/10/2024
Al Rajhi Capital issues Q3 2024 earnings forecasts for more Tadawul-listed firms
Argaam
06/10/2024
United Securities: As earnings loom, what to expect in Q3 2024?
Argaam
09/09/2024
Saudi pharmaceuticals sector seen to grow: Al Rajhi Capital
ِArgaam
02/09/2024
Board member, senior exec ownership changes in Tadawul on Aug. 28
Argaam Special
21/08/2024
United Securities assigns rating, TP for SPIMACO
Argaam
19/08/2024
SPIMACO holds 6% of market, seeks 12% revenue growth
Argaam Special
31/07/2024
SPIMACO, Altos Biologics sign deal to produce, market ALT-L9 in 16 key markets
Argaam
28/07/2024
What analysts expect from SPIMACO Q2 2024 results?
Argaam Special
16/07/2024
United Securities issues Q2 earnings estimates
Argaam
04/07/2024
Al Rajhi Capital issues Q2 2024 profit forecasts
Argaam
13/06/2024
SPIMACO plans to appoint new external auditor
Argaam
08/05/2024
SPIMACO net profit expected to rise in Q1 2024
Argaam Special
21/04/2024
SPIMACO committed to expansion of complex products, focuses on African markets: CEO
Argaam
21/04/2024
Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023
Argaam Special
16/04/2024
Highest-paid executives, board members of Saudi-listed firms in 2023
Argaam Special
06/04/2024
Al Rajhi Capital issues Q1 profit forecasts for TASI-listed firms
Argaam
04/04/2024
SPIMACO continues deleveraging with robust financial position: CEO
Argaam
31/03/2024
SPIMACO board proposes to withhold 2023 dividends
Argaam
21/02/2024
SPIMACO appoints Jérôme Cabannes as CEO
Argaam

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2025, Argaam Investment, All Rights Reserved
Call Request